A new frontier: Navigating hospital pharmacy practice during the COVID-19 pandemic

被引:0
作者
Bairagdar, Nora [1 ]
Antigua, Abigail Dee [1 ]
Al-Said, Mohammed [1 ]
Barnett, Kacee [1 ]
Manigaba, Kayihura [1 ]
机构
[1] North Florida Reg Med Ctr, Dept Clin Pharm, Gainesville, FL 32605 USA
来源
JOURNAL OF RESEARCH IN PHARMACY | 2021年 / 25卷 / 06期
关键词
COVID-19; pandemic; hospital pharmacy; hospital pharmacist; collaboration; challenges;
D O I
10.29228/jrp.73
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), first manifested in Wuhan, China in December 2019 as multiple cases of pneumonia with unknown etiology. This was the herald of an infectious catastrophe that would eventually affect millions of people across the world, claim countless lives, and uproot the very foundations of modern-day healthcare practice. Hospital pharmacists, alongside with physicians, nurses, and numerous other disciplines, are an integral part of the healthcare team that responded to this pandemic. The purpose of this article is to highlight the teamwork, determination, and innovativeness demonstrated by clinical pharmacists at a 510-bed community hospital in response to the coronavirus disease of 2019 (COVID-19). Pharmacists rose to the occasion to ensure that patients continue to receive the best therapy possible during this pandemic, and they supported other disciplines to ensure a collaborative response. Despite the unprecedented challenges posed to hospital pharmacy practice in the setting of COVID-19, our pharmacy team's response has resoundingly proven the resiliency of the human spirit, and shows that nothing is insurmountable in the face of collaboration, creativity, and an overwhelming desire to care for our community.
引用
收藏
页码:823 / 827
页数:5
相关论文
共 12 条
[1]  
American Society of Hospital Pharmacists, ASS EV COVID 19 REL
[2]   Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected. Interim guidance [J].
不详 .
PEDIATRIA I MEDYCYNA RODZINNA-PAEDIATRICS AND FAMILY MEDICINE, 2020, 16 (01) :9-26
[3]  
Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]
[4]  
Hospital Pharmacy Europe, ROL PHARM MULT TEAM
[5]  
Manigaba Kayihura, 2020, HCA Healthc J Med, V1, P247, DOI 10.36518/2689-0216.1093
[6]  
Martellucci Cecilia Acuti, 2020, Advances in Biological Regulation, V77, P100730, DOI [10.1016/j.jbior.2020.100730, 10.1016/j.jbior.2020.100736]
[7]   COVID-19 diagnosis and management: a comprehensive review [J].
Pascarella, Giuseppe ;
Strumia, Alessandro ;
Piliego, Chiara ;
Bruno, Federica ;
Del Buono, Romualdo ;
Costa, Fabio ;
Scarlata, Simone ;
Agro, Felice Eugenio .
JOURNAL OF INTERNAL MEDICINE, 2020, 288 (02) :192-206
[8]   Hospitalized COVID-19 Patients and Venous Thromboembolism A Perfect Storm [J].
Spyropoulos, Alex C. ;
Weitz, Jeffrey I. .
CIRCULATION, 2020, 142 (02) :129-132
[9]   Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy [J].
Tang, Ning ;
Bai, Huan ;
Chen, Xing ;
Gong, Jiale ;
Li, Dengju ;
Sun, Ziyong .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2020, 18 (05) :1094-1099
[10]  
The American Journal of Managed Care, 2020, TIM COVID 19 DEV 202